Is platelet activating factor (PAF) an important mediator in bronchial asthma?
The development of selective PAF receptor antagonists may provide a novel approach to the treatment of human bronchial asthma. In preclinical animal models of human asthma, PAF receptor antagonists have been found to be efficacious in blocking antigen-induced changes in lung function. However, the m...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Hindawi Limited,
1992-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|